GlobalData on MSN3d
GSK gains approval in Japan for extended indication of RSV vaccine
GlaxoSmithKline (GSK) has received approval from Japan's Ministry of Health, Labour and Welfare (MHLW) for its regulatory ...
GSK's RSV vaccine gets Japan approval for adults aged 50 to 59
GSK said on Friday that its respiratory syncytial virus (RSV) vaccine has received approval in Japan for expanded use in ...
ジャパンタイムズ15h
Deadline for ‘catch-up’ HPV vaccination program extended until March
The revised timeline allows eligible women to receive their first dose by the end of March 2025 and complete the remaining ...
WHO lists mpox vaccine by Japan's KM Biologics for emergency use
The World Health Organization listed KM Biologics' mpox vaccine for emergency use on Tuesday, making it the second shot to ...
New mpox vaccines for Congo’s children held up by old problem
LONDON/KINSHASA - Adults started getting vaccinations against mpox in Democratic Republic of Congo's capital this week. But ...
ジャパンタイムズ8d
WHO approves Japanese pharmaceutical company's mpox vaccine
The listing from the World Health Organization paves the way for countries worldwide to quickly approve and import the ...
NHK7d
WHO permits emergency use of Japan-made mpox vaccine
The World Health Organization has permitted emergency use of a Japanese vaccine to inoculate against mpox, previously known ...
TheCable8d
WHO approves Japanese mpox vaccine for emergency use
The World Health Organisation (WHO) has granted emergency use listing (EUL) for the LC16m8 mpox vaccine. This would be the ...
Anadolu Ajansi8d
World Health Organization approves 2nd mpox vaccine from Japan
Largest donation so far, Japan to donate 3.05M doses of LC16m8 vaccine produced by KM Biologics - Anadolu Ajansı ...
Analysis-New Mpox Vaccines for Congo's Children Held up by Old Problem
Japan pledged in September to donate three million doses from its national stockpile of LC16m8 vaccines, first developed by ...
Japan Today6d
WHO OKs emergency use of Japanese mpox vaccine
The World Health Organization has granted emergency use of a Japanese mpox vaccine, its second approval of a product to inoculate against the infectious disease, to combat a recent outbreak mainly in ...